Nephros, Inc. NEPH
2.84 USD -0.05 (-1.73%)
Regular-session close
2.90 +0.06 +2.11%
After hours · Nov 19, 7:41 PM ET
2.82 Day range 2.99
2.78 52-week range 5.79
- YTD
- -41.80%
- 1 year
- -43.54%
Analyst view
Price target (mean) 4.75 +67.3% upside
Now 2.84
- Target (low)
- 4.50
- Target (mean)
- 4.75
- Target (high)
- 5.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.015 | -0.02 – -0.01 | -0.06 | +75.0% | 3.57M | +9.7% | 2 |
| Next quarter | -0.01 | -0.01 – -0.01 | -0.02 | +50.0% | 3.60M | +2.3% | 1 |
| Current year | -0.04 | -0.05 – -0.03 | -0.15 | +73.3% | 13.86M | -2.6% | 2 |
| Next year | 0.02 | 0.02 – 0.02 | -0.04 | +150.0% | 15.13M | +9.1% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 12, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| May 15, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Mar 8, 2024 | Benchmark | Upgrade | Hold | Speculative Buy |
| Jan 26, 2021 | B. Riley Securities | Initiated | — | Buy |
| Oct 24, 2019 | Benchmark | Initiated | — | Speculative Buy |
| Oct 4, 2019 | Maxim Group | Initiated | — | Buy |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
